Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875636 · ClinicalTrials.gov registry record
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 260
- Enrollment target
NCT05875636 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 260 participants.
The verdict
NCT05875636 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.
Interventions
- OTHER Esophagogastroduodenoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2024-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05875636
The ClinicalTrials.gov registry entry for NCT05875636 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Esophagogastroduodenoscopy is the first listed.
NCT05875636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05875636 about?
NCT05875636 is a clinical study titled "GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy". This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively ob...
What is the current status of trial NCT05875636?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2023-08-21. Estimated completion is 2024-08-23.
What interventions are being tested in trial NCT05875636?
The interventions under investigation include: Esophagogastroduodenoscopy (OTHER).
Who is sponsoring clinical trial NCT05875636?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.